Literature DB >> 17569114

Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX2 tumor in rabbits by intravenous injection.

Jun Hu1, Zhi-Su Liu, Sheng-Li Tang, Yue-Ming He.   

Abstract

AIM: To evaluate the effect of hydroxyapatite nano-particles (Nano HAP) by intravenous injection on the inhibition of implanted hepatic VX(2) tumor growth in rabbits and cell p53/c-Myc protein expression.
METHODS: 60 hepatic VX(2) tumor-bearing rabbits was randomly divided into five groups. Nano HAP collosol 20 mg/kg, 40 mg/kg, 5-FU solutions 20 mg/mL, mixed liquor of 5-FU solution 20 mg/mL and Nano HAP collosol 20 mg/kg were infused by vein, normal saline conducted as the control. The general state, weight, liver function and gross tumor volume were detected dynamically. The expression of p53 and c-Myc gene protein in tumor tissue was detected by immunohistochemistry methods.
RESULTS: The growth of implanted hepatic VX(2) tumors was significantly inhibited in all therapy groups, 3 wk after the injection, the tumor control rates in Nano HAP collosol groups were 25.5% and 32.5% respectively, and the gross tumor volumes were obviously less than that of control group. (24.81 +/- 5.17 and 22.73 +/- 4.23 vs 33.32 +/- 5.26, P<0.05). The tumor control rate of 5-FU group was 43.7% (18.74 +/- 4.40 vs 33.32 +/- 5.26, P<0.05), but the general state of the animals after injection aggravated; and the adverse reaction in the drug combination group obviously decreased. Due to the effect of Nano HAP, the positive expression of tumor associated the mutated p53 and c-Myc in tumor tissue was decreased obviously compared with the control group.
CONCLUSION: Nano HAP has evident inhibitory action on rabbit implanted hepatic VX(2) tumor in vivo, which may be the result of decreasing the expression of the mutated p53 and c-myc, and drug combination can obviously decrease the adverse reaction of 5-FU.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569114      PMCID: PMC4395630          DOI: 10.3748/wjg.v13.i20.2798

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  Tissue response to porous hydroxyapatite ceramic in the human femoral head.

Authors:  Yomei Tachibana; Setsuo Ninomiya; Yoon Taek Kim; Miyoko Sekikawa
Journal:  J Orthop Sci       Date:  2003       Impact factor: 1.601

2.  In vitro assessment of the biological response to nano-sized hydroxyapatite.

Authors:  J Huang; S M Best; W Bonfield; R A Brooks; N Rushton; S N Jayasinghe; M J Edirisinghe
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

3.  The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions.

Authors:  Silvia Pezzatini; Raffaella Solito; Lucia Morbidelli; Stefania Lamponi; Elisa Boanini; Adriana Bigi; Marina Ziche
Journal:  J Biomed Mater Res A       Date:  2006-03-01       Impact factor: 4.396

4.  Effects of nano HAP on biological and structural properties of glass bone cement.

Authors:  Qiang Fu; Nai Zhou; Wenhai Huang; Deping Wang; Liying Zhang; Haifeng Li
Journal:  J Biomed Mater Res A       Date:  2005-08-01       Impact factor: 4.396

5.  Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells.

Authors:  Zhi-Su Liu; Sheng-Li Tang; Zhong-Li Ai
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  The adsorptive properties of hydroxyapatite to albumin, dextran and lipids.

Authors:  M Niwa; W Li; T Sato; T Daisaku; H Aoki; H Aoki
Journal:  Biomed Mater Eng       Date:  1999       Impact factor: 1.300

Review 7.  Collagen-hydroxyapatite composites for hard tissue repair.

Authors:  D A Wahl; J T Czernuszka
Journal:  Eur Cell Mater       Date:  2006-03-28       Impact factor: 3.942

8.  Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.

Authors:  Michael A Rauschmann; Thomas A Wichelhaus; Volker Stirnal; Elvira Dingeldein; Ludwig Zichner; Reinhard Schnettler; Volker Alt
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

9.  Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs.

Authors:  Yutaka Mizushima; Toshiyuki Ikoma; Jyunzo Tanaka; Keiko Hoshi; Tsutomu Ishihara; Yasuaki Ogawa; Akinori Ueno
Journal:  J Control Release       Date:  2005-11-28       Impact factor: 9.776

10.  Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer.

Authors:  K Kunieda; T Seki; S Nakatani; M Wakabayashi; T Shiro; K Inoue; M Sougawa; R Kimura; K Harada
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more
  9 in total

1.  Development of a VX2 pancreatic cancer model in rabbits: a pilot study.

Authors:  Aaron C Eifler; Robert J Lewandowski; Sumeet Virmani; Johnathan C Chung; Dingxin Wang; Richard L Tang; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Robert K Ryu; Riad Salem; Andrew C Larson; Eric Cheon; Matthew Strouch; David J Bentrem; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2009-06-28       Impact factor: 3.464

2.  E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.

Authors:  Wei-Yuan Wei; Lin-Hai Yan; Xiao-Tong Wang; Lei Li; Wen-Long Cao; Xiao-Shi Zhang; Ze-Xu Zhan; Han Yu; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 3.  Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.

Authors:  Nattawut Leelakanok; Sean Geary; Aliasger Salem
Journal:  J Pharm Sci       Date:  2017-10-16       Impact factor: 3.784

Review 4.  Integrative nanomedicine: treating cancer with nanoscale natural products.

Authors:  Iris R Bell; Barbara Sarter; Mary Koithan; Prasanta Banerji; Pratip Banerji; Shamini Jain; John Ives
Journal:  Glob Adv Health Med       Date:  2014-01

5.  Amorphous calcium phosphate nanoparticles could function as a novel cancer therapeutic agent by employing a suitable targeted drug delivery platform.

Authors:  Milad Pourbaghi-Masouleh; Vahid Hosseini
Journal:  Nanoscale Res Lett       Date:  2013-10-30       Impact factor: 4.703

6.  Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Zhi-Qiang Li
Journal:  Int J Nanomedicine       Date:  2012-07-12

Review 7.  Fabrication, Properties and Applications of Dense Hydroxyapatite: A Review.

Authors:  Mythili Prakasam; Janis Locs; Kristine Salma-Ancane; Dagnija Loca; Alain Largeteau; Liga Berzina-Cimdina
Journal:  J Funct Biomater       Date:  2015-12-21

8.  Facile Synthesis, Characterization, and Cytotoxic Activity of Europium-Doped Nanohydroxyapatite.

Authors:  Paulina-Guadalupe Miranda-Meléndez; Gabriel-Alejandro Martínez-Castañón; Nereyda Niño-Martínez; Nuria Patiño-Marín; Miguel-Ángel Casillas-Santana; Brenda-Erendida Castillo-Silva; Facundo Ruiz
Journal:  Bioinorg Chem Appl       Date:  2016-11-14       Impact factor: 7.778

9.  Influence of spray-dried hydroxyapatite-5-fluorouracil granules on cell lines derived from tissues of mesenchymal origin.

Authors:  Tim Scharnweber; Catarina Santos; Ralf-Peter Franke; Maria Margarida Almeida; Maria Elisabete V Costa
Journal:  Molecules       Date:  2008-11-01       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.